CANNPRISMA is a company incorporated in 2018 with 100% Portuguese capital, with a strategy integrated in a vertical model that covers cultivation, transformation, production, the “white label”, distribution and research.
It was created with the purpose of to meet the emerging needs of the pharmaceutical industry related to the field of medical cannabis.
Its main objective is to provide GACP and GMP products based on medicinal cannabis, innovative and of reference in the market that contribute to improve the quality of life of the largest possible number of people.
Our employees are highly qualified, trained, competent and motivated and they are truly responsible for achieving our goals.
To ensure that our products and the entire organizational structure are within the highest standards of compliance required by the sector and the applicable legislation (INFARMED), we bet on a effective Quality Control and a Quality, Environment and Safety Management System that supports the organization’s entire strategy, decision making and continuous improvement of the production processes and the commercial area.
Chatterbox
Parents: Slurricane x Margy Mints
Further National Health-Service Information on